バイオフォトニクスの市場規模、シェア、成長分析、技術別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

バイオフォトニクス市場規模は2023年に652億米ドルとなり、予測期間（2025-2032年）のCAGRは11.4%で、2024年の726億3,000万米ドルから2032年には1,722億7,000万米ドルに成長する見通しです。

世界のバイオフォトニクス市場は、非侵襲的診断技術に対する需要の高まりによって大きな成長を遂げています。従来の方法では侵襲的な処置を伴うことが多く、患者にリスクや不快感を与えています。バイオフォトニクスは、生体組織を分析するために光ベースの技術を利用し、外科的介入を伴わない正確でリアルタイムの画像ソリューションを提供します。眼科における光コヒーレンストモグラフィ（OCT）のような技術は、眼疾患の早期発見を容易にし、蛍光画像はがん診断を向上させます。ヘルスケアシステムが安全性と効率性を優先するにつれて、バイオフォトニクスの採用が加速します。ナノフォトニクスと分子イメージングの進歩により、画像の解像度がさらに向上し、病気の初期徴候の検出が可能になります。量子ドットやプラズモニックナノ粒子による革新はバイオセンシングに革命をもたらし、疾患バイオマーカーの特異性を向上させています。このような技術進化は、診断や個別化医療におけるバイオフォトニクスの応用範囲を広げ、市場拡大を牽引しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

バイオフォトニクス市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 体外
• 生体内

バイオフォトニクス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• シースルーイメージング
• 顕微鏡検査
• イメージングの内側
• スペクトロモレキュラー
• アナリティクスセンシング
• 光療法
• 表面イメージング
• バイオセンサー

バイオフォトニクス市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• テストとコンポーネント
• 医療治療
• 医療診断
• 非医療用途

バイオフォトニクス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Carl Zeiss AG（Germany）
• Olympus Corporation（Japan）
• Thorlabs, Inc.（USA）
• Hamamatsu Photonics K.K.（Japan）
• Nikon Corporation（Japan）
• Coherent, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Bruker Corporation（USA）
• ZEISS Group（Germany）
• Horiba, Ltd.（Japan）
• Photonics Industries International, Inc.（USA）
• MKS Instruments, Inc.（USA）
• Edmund Optics, Inc.（USA）
• Jenoptik AG（Germany）

結論と提言

Biophotonics Market size was valued at USD 65.2 billion in 2023 and is poised to grow from USD 72.63 billion in 2024 to USD 172.27 billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The global biophotonics market is experiencing significant growth driven by the increasing demand for non-invasive diagnostic technologies. Traditional methods often involve invasive procedures, posing risks and discomfort for patients. Biophotonics utilizes light-based techniques to analyze biological tissues, offering accurate, real-time imaging solutions without surgical intervention. Technologies like optical coherence tomography (OCT) in ophthalmology facilitate early detection of eye diseases, while fluorescence imaging enhances cancer diagnosis. As healthcare systems prioritize safety and efficiency, biophotonics adoption accelerates. Advancements in nanophotonics and molecular imaging further enhance image resolution and enable detection of early disease signs. Innovations with quantum dots and plasmonic nanoparticles are revolutionizing biosensing, improving the specificity of disease biomarkers. This technological evolution is broadening the applications of biophotonics in diagnostics and personalized medicine, driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biophotonics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biophotonics Market Segments Analysis

Global Biophotonics Market is segmented by Technology, Application, End Use and region. Based on Technology, the market is segmented into In-Vitro and In-Vivo. Based on Application, the market is segmented into See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging and Biosensors. Based on End Use, the market is segmented into Tests and Components, Medical Therapeutics, Medical Diagnostics and Non-medical Application. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biophotonics Market

The global biophotonics market is primarily driven by the rising demand for non-invasive medical techniques. This innovative field facilitates real-time, high-resolution imaging, which is essential for early detection of diseases and the advancement of precision medicine. As instances of cancer, neurological conditions, and cardiovascular diseases continue to rise, healthcare professionals are increasingly turning to biophotonic technologies. These solutions not only ensure safer diagnostic procedures but also enhance the effectiveness of treatment options, making them a preferred choice in modern healthcare. Consequently, the growing inclination towards biophotonics is significantly propelling the market forward.

Restraints in the Biophotonics Market

The Biophotonics market faces significant constraints primarily due to the high costs associated with its devices and infrastructure, which serve as major hindrances to market growth. The advanced nature of optical imaging systems, laser-based diagnostics, and biosensors requires considerable financial investment, making these technologies less accessible, particularly in developing regions. Moreover, the necessity for skilled professionals to effectively operate these sophisticated technologies exacerbates the overall implementation costs. As a result, these factors collectively impede the widespread adoption and expansion of biophotonics solutions, limiting their potential impact in various sectors, particularly in areas that could greatly benefit from such advancements.

Market Trends of the Biophotonics Market

The biophotonics market is witnessing a significant shift towards personalized healthcare solutions, exemplified by innovative startups like Luma Biophotonics. Established in 2021, Luma is at the forefront of this trend, delivering compact, cost-effective home diagnostic devices that empower individuals to monitor their health conveniently. Utilizing advanced Photonic Integrated Circuits (PICs), their flagship analyzer facilitates multianalyte testing, enabling timely health insights while reducing reliance on clinical visits. The development of polymeric PICs, which offer comparable performance to traditional silicon variants at lower costs, exemplifies a crucial advancement. This democratization of advanced diagnostics not only enhances early disease detection but also promotes tailored treatment approaches, driving substantial growth in the biophotonics market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biophotonics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• In-Vitro
• In-Vivo

Global Biophotonics Market Size by Application & CAGR (2025-2032)

• Market Overview
• See-Through imaging
• Microscopy
• Inside Imaging
• Spectro Molecular
• Analytics Sensing
• Light Therapy
• Surface Imaging
• Biosensors

Global Biophotonics Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Tests and Components
• Medical Therapeutics
• Medical Diagnostics
• Non-medical Application

Global Biophotonics Market Size & CAGR (2025-2032)

• North America (Technology, Application, End Use)
  • US
  • Canada
• Europe (Technology, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Carl Zeiss AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorlabs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coherent, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Photonics Industries International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MKS Instruments, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edmund Optics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jenoptik AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations